hGH Fragment 176-191 Research Compound

AOD-9604 (5mg) will be supplied in Australia by Daza Enhanced with fast domestic shipping to all states and territories.

AOD-9604 is a modified C-terminal fragment of human growth hormone (hGH) — amino acids 176–191 with an added tyrosine residue. It was developed at Monash University in Melbourne — one of the few peptides with Australian scientific origins. The research design isolated hGH’s fat-metabolising properties from its insulin-like and IGF-1 elevating effects.

Mechanistically, AOD-9604 is studied for direct action on adipose tissue — stimulating lipolysis (fat breakdown) and inhibiting lipogenesis (fat storage) — without affecting insulin sensitivity or IGF-1 levels.

Key Research Areas

• Adipose Tissue Research — Studied for lipolysis and lipogenesis modulation in visceral and subcutaneous fat
• Metabolic Profile — Studied as a fat-loss alternative to full hGH without IGF-1 elevation or glucose impairment
• Cartilage Research — Emerging research on cartilage and joint tissue effects
• Obesity Models — Studied in diet-induced obesity animal models

Supplied as lyophilized powder at high purity, verified by HPLC and mass spectrometry. 5mg per vial. Fast domestic shipping across Australia.

⚠ For in-vitro research and laboratory use only. Not for human consumption.